A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score

Intern Emerg Med. 2012 Jun;7(3):291-2. doi: 10.1007/s11739-012-0784-y. Epub 2012 May 1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Confidence Intervals
  • Fibrinolytic Agents / therapeutic use*
  • Health Status Indicators
  • Humans
  • Nadroparin / therapeutic use*
  • Neoplasms / complications*
  • Neoplasms / drug therapy
  • Predictive Value of Tests
  • Risk
  • Risk Assessment / methods*
  • Risk Factors
  • Venous Thromboembolism / diagnosis*
  • Venous Thromboembolism / etiology
  • Venous Thromboembolism / prevention & control

Substances

  • Antineoplastic Agents
  • Fibrinolytic Agents
  • Nadroparin